Download PDF
Hebamme 2017; 30(01): 27-33
DOI: 10.1055/s-0042-122472
SCHWERPUNKT
Präeklampsie
Hippokrates Verlag in Georg Thieme Verlag KG Stuttgart

Präeklampsie: Screening und Management

Dietmar Schlembach
Gynäkologe, Berlin
› Author Affiliations
Further Information

Publication History

Publication Date:
01 March 2017 (online)

Also available at
    Permissions and Reprints

Hypertensive Schwangerschaftserkrankungen (HES) treten in ca. 6–8 % aller Schwangerschaften auf. Nach wie vor stellen sie große Herausforderungen an das geburtshilfliche Team und sind entscheidend verantwortlich für maternale und fetale bzw. neonatale Morbidität und Mortalität. Ein Präeklampsie-Risikoscreening bietet die Chance zur Früherkennung und rechtzeitigen prophylaktischen Medikation.

 

  • Literatur

  • 1 Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, Harper A, Hulbert D, Lucas S, McClure J, Millward-Sadler H, Neilson J, Nelson-Piercy C, Norman J, O’Herlihy C, Oates M, Shakespeare J, de Swiet M, Williamson C, Beale V, Knight M, Lennox C, Miller A, Parmar D, Rogers J, Springett A. Saving mothers’ lives: Reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118 Suppl 1: 1-203
    PubMedGoogle Scholar
  • 2 Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2 (6): e323-333
    CrossrefPubMedGoogle Scholar
  • 3 Shih T, Peneva D, Xu X, Sutton A, Triche E, Ehrenkranz RA, Paidas M, Stevens W. The Rising Burden of Preeclampsia in the United States Impacts Both Materrnal and Child Health. Am J Perinatol 2016; 33 (4): 329-338
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Akolekar R, Syngelaki A, Poon L, Wright D, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagn Ther 2013; 33 (1): 8-15
    CrossrefPubMedGoogle Scholar
  • 5 AWMF 015/018-S1-Leitlinie 2013 Diagnostik und Therapie hypertensiver Schwangerschaftserkrankungen. ( http://www.awmf.org/uploads/tx_szleitlinien/015-018l_S1_Diagnostik_Therapie_hypertensiver_Schwangerschaftserkrankungen_2014-01.pdf )
    Google Scholar
  • 6 Ahmed R, Dunford J, Mehran R, Robson S, Kunadian V. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 2014; 63 (18): 1815-1822
    CrossrefPubMedGoogle Scholar
  • 7 Melchiorre K, Thilaganathan B. Maternal cardiac function in preeclampsia. Curr Opin Obstet Gynecol 2011; 23 (6): 440-447
    CrossrefPubMedGoogle Scholar
  • 8 Schlembach D. Pre-eclampsia – still a disease of theories. Fukushima J Med Sci 2003; 49 (2): 69-115
    CrossrefPubMedGoogle Scholar
  • 9 Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308 (5728): 1592-1594
    CrossrefPubMedGoogle Scholar
  • 10 Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008; 51 (4): 970-975
    CrossrefPubMedGoogle Scholar
  • 11 Leslie K, Thilaganathan B, Papageorghiou A. Early prediction and prevention of preeclampsia. Best Pract res Clin Obstet Gynaecol 2011; 25 (3): 343-354
    CrossrefPubMedGoogle Scholar
  • 12 Rodriguez A, Tuuli mg, Odibo AO. First-, Second-, and Third-Trimester Screening for Preeclampsia and Intrauterine Growth Restriction. Clin Lab Med 2016; 36 (2): 331-351
    CrossrefPubMedGoogle Scholar
  • 13 Kane SC. Fist trimester screening for preeclampsia. Obstet Med 2016; 9 (3): 106-112
    CrossrefPubMedGoogle Scholar
  • 14 O’Gorman N, Nicolaides KH, Poon LC. The use of ultrasound and other markers for early detection of preeclampsia. Womens Health (Lond) 2016; 12 (2): 199-207
    PubMedGoogle Scholar
  • 15 Yücel B, Gedikbasi A, Dündar O, Olgac Y, Yildirim D, Yildirim G, Polat I. The utility of first trimester uterine artery Doppler, placental volume and PAPP-A levels alone and in combination to predict preeclampsia. Pregnancy Hypertens 2016; 6 (4): 269-273
    CrossrefPubMedGoogle Scholar
  • 16 Khong SL, Kane SC, Brennecke SP, da Silva Costa F. First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications. Dis Markers; 2015 2015: 679730
    PubMedGoogle Scholar
  • 17 Zhong Y, Zhu F, Ding Y. Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis. BMC Pregnancy Childbirth 2015; 15: 191
    CrossrefPubMedGoogle Scholar
  • 18 Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH. Combined screening for preeclampsia and small for gestational age at 11-13 weeks. Fetal Diagn Ther 2013; 33 (1): 16-27
    CrossrefPubMedGoogle Scholar
  • 19 Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011; 31 (1): 66-74
    CrossrefPubMedGoogle Scholar
  • 20 Kuc S, Wortelboer EJ, Rijn BB van, Franx A, Visser GH, Schielen PC. Evaluation of 7 serum biomarkers and uterine artery Doppler ultrasound for first-trimester prediction of preeclampsia: a systematic review. Obstet Gynecol Surv 2011; 66 (4): 225-239
    CrossrefPubMedGoogle Scholar
  • 21 Audibert F, Boucoiran I, An N, Aleksandrov N, Delvin E, Bujold E, Rey E. Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women. Am J Obstet Gynecol 2010; 203 (4): 383.e1-8
    Google Scholar
  • 22 Bahado-Singh RO, Jodicke C. Uterine artery Doppler in first trimester pregnancy screening. Clin Obstet Gynecol 2010; 53 (4): 879-887
    CrossrefPubMedGoogle Scholar
  • 23 Simeone S, Lojo C, Garcia-Esteve L, Triunfo S, Crovetto F, Arranz A, Gratacós E, Figueras F. Psychological impact of first-trimester prevention for preeclampsia on anxiety. Prenat Diagn 2015; 35 (1): 60-64
    CrossrefPubMedGoogle Scholar
  • 24 Harris JM, Franck L, Green B, Michie S. The psychological impact of providing women with risk information for preeclampsia: a qualitative study. Midwifery 2014; 30 (12): 1187-1195
    CrossrefPubMedGoogle Scholar
  • 25 East C, Conway K, Pollock W, Frawley N, Brennecke S. Women’s experiences of preeclampsia: Australian action on preeclampsia survey of women and their confidants. J Pregnancy 2011; 2011: 375653
    PubMedGoogle Scholar
  • 26 Bujold E, Roberge S, Nicolaides KH. Low-dose aspirin for prevention of adverse outcomes related to abnormal placentation. Prenat Diagn 2014; 34 (7): 642-648
    PubMedGoogle Scholar
  • 27 Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Abrashi A, Bujold E. Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31 (3): 141-146
    CrossrefPubMedGoogle Scholar
  • 28 Hofmeyr GJ, Belizán JM, Dadelszen P von. Calcium and Pre-eclampsia (CAP) Study Group. Low dose calcium supplementation for preventing pre-eclampsia: a systematic review and commentary. BJOG 2014; 121 (8): 951-957
    CrossrefPubMedGoogle Scholar
  • 29 Rodger MA, Hague WM, Kingdom J, Kahn SR, Karovitch A, Sermer M, Clement AM, Coat S, Chan WS, Said J, Rey E, Robinson S, Khurana R, Demers C, Kovacs MJ, Solymoss S, Hinshaw K, Dwyer J, Smith G, McDonald S, Newstead-Angel J, McLeod A, Khandelwal M, Silver RM, Le Gal G, Greer IA, Keely E, Rosene-Montella K, Walker M, Wells PS. TIPPS Investigators. Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial. Lancet 2014; 384 (9955): 1673-1683
    CrossrefPubMedGoogle Scholar
  • 30 Gesund schwanger. Alles, was jetzt wichtig ist. EFCNI. ( http://www.efcni.org/fileadmin/Daten/Web/Pregnancy/14_06_12_Neuauflage_Gesund_schwanger.pdf )
    Google Scholar
  • 31 Rana S, Powe CE, Salahuddin S, Ver-lohren S, Perschel FH, Levine RJ, Lim KH, Wenger JB, Thadhani R, Karumanchi SA. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012; 125 (7): 911-919
    CrossrefPubMedGoogle Scholar
  • 32 Verlohren S, Herraiz I, Lapaire O, Schlembach D, Moertl M, Zeisler H, Calda P, Holzgreve W, Galindo A, Engels T, Denk B, Stepan H. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol 2012; 206 (1): 58.e1-8
    CrossrefPubMedGoogle Scholar
  • 33 Schlembach D, Verlohren S, Klein E, Lapaire O, Ramoni A, Stepan H. für die Internationale Konsensusgruppe zum Einsatz des sFlt-1/PlGF-Quotienten in der Schwangerschaft Der sFlt-1/PlGF-Quotient in Prädiktion und Diagnostik der Präeklampsie. Frauenarzt 2015; 56 (10): 858-866
    Google Scholar